Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.20
-1.33 (-0.58%)
AAPL  277.48
-1.30 (-0.47%)
AMD  220.50
+2.53 (1.16%)
BAC  53.89
-0.06 (-0.11%)
GOOG  316.85
-5.24 (-1.63%)
META  668.89
-4.53 (-0.67%)
MSFT  488.74
+5.58 (1.15%)
NVDA  184.20
+1.79 (0.98%)
ORCL  220.16
+2.57 (1.18%)
TSLA  441.64
-13.36 (-2.94%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.